Bibliography for: "Income Opportunity Realty Investors, Inc. Announces a 3-for-1 Stock Split"

"Income Opportunity Realty Investors, Inc. Announces a 3-for-1 Stock Split". Business Wire. FindArticles.com. 30 Dec, 2009. http://findarticles.com/p/articles/mi_m0EIN/is_2005_May_14/ai_n13718612/

Business Wire

View more issues:

Articles in May 14, 2005 issue of Business Wire

• CyberAds' CEO Walt Tatum to Be Interviewed on Radio to Discuss XBoard on Saturday, May 14, 2005
• George Mark Children's House Hosts First Annual San Francisco Gala for Children with Life-Limiting and Terminal Illnesses and Their Families
• Contestants Win a Total of $290,000 on ''The Big Spin'' Show
• Point Therapeutics Announces Positive Results in Phase 2 Metastatic Melanoma Program
• Counties Commend Governor's Commitment to Local Government; Key Funding Included in May Revision of State Budget
• Income Opportunity Reports 1Q 2005 Results
• NAR Building Given High Environmental Award by Green Building Council
• Natrol Reports First Quarter Earnings
• Minnesota Chapter of American Marketing Association Announces June Program: ''Use Your Own Brand to Drive Your Career Development''
• Phoenix Matachewan Mines Inc.: $512,250 Private Placement Completed
• Bentley President to Lead Albany International Corp
• Cannes Film Festival Red Carpet Arrivals and Premiere Party Footage of 'Kiss Kiss, Bang Bang'; Satellite Feed — Sunday, May 15, 2005
• Income Opportunity Realty Investors, Inc. Announces a 3-for-1 Stock Split
• Former professor inspires $1 million gift to the University of Oregon
• Cyclacel Reports CYC682 Phase I Data at 2005 ASCO
• James Heiting Elected State Bar of California President
• Quinta and Thomson Back Luc Besson's `La Cite du Cinema' Project
• Cyclists Are Oklahoma-Bound after Saturday Kick-Off of the 19th Annual FedEx Kinko's MS 150 Bike Tour
• Cytokinetics Announces Interim Phase I Results for SB-743921 at the 2005 Annual Meeting of the American Society of Clinical Oncology
• Merck Announces Phase II Study Results of SAHA in Advanced, Refractory Cutaneous T-cell Lymphoma - CTCL - Patients
• NAR Takes Initiative to Resolve VOW Policy Dispute